Abstract
Interleukin-2 (IL-2) remains the mainstay of treatment for metastatic renal cell carcinoma (RCC), but minimally invasive surgical techniques have provided new options for the combined treatment of RCC. Two patients with metastatic RCC to the head and neck treated by combined laser-induced thermal therapy and IL-2 were described in this case report. Both patients had an extended survival compared to the historical survival of 10 months for metastatic RCC but eventually succumbed to progressive disease. The authors’ initial experience with metastatic RCC suggests that laser thermoablation and immunotherapy in selected patients with metastatic RCC is warranted as a palliative treatment, but a larger study with long-term follow-up is necessary to determine the effectiveness of this approach.
Similar content being viewed by others
References
Rohde D, Albers C, Mahnken A et al (2003) Regional thermoablation of local or metastatic renal cell carcinoma. Oncol Rep 10:753–757
Paiva MB, Blackwell KE, Saxton RE et al (2002) Nd:YAG laser therapy for palliation of recurrent squamous cell carcinomas in the oral cavity. Lasers Surg Med 31:64–69
Brown DH (2000) The versatile contact Nd:YAG laser in head and neck surgery: an in vivo and clinical analysis. Laryngoscope 110:854–867
Paiva MB, Graeber IP, Castro DJ et al (1998) Laser and cisplatinum for treatment of human squamous cell carcinoma. Laryngoscope 108:1269–1276
Paiva M, Saxton R, Blackwell K et al (2000) Combined cisplatinum and laser thermal therapy for palliation of recurrent head and neck tumors. Diagn Ther Endosc 6:133–140
Gottlieb MD, Roland JT Jr (1998) Paradoxical spread of renal cell carcinoma to the head and neck. Laryngoscope 108:1301–1305
Simo R, Sykes AJ, Hargreaves SP et al (2000) Metastatic renal cell carcinoma to the nose and paranasal sinuses. Head Neck 22:722–727
Franklin JR, Figlin R, Rauch J et al (1996) Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience. Semin Urol Oncol 14:230–236
Patard JJ, Leray E, Rioux-Leclercq N et al (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23:2763–2771
Campbell SC, Flanigan RC, Clark JI (2003) Nephrectomy in metastatic renal cell carcinoma. Curr Treatm Opt Oncol 4:363–372
Bex A, Horenblas S, de Gast GC (2003) The timing of immunotherapy and nephrectomy in multimodality treatment of metastatic renal cell carcinoma. Technol Cancer Res Treat 2:205–210
Belldegrun A, Shvarts O, Figlin RA (2000) Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma. Cancer J Sci Am 6(Suppl 1):S88–S92
Figlin RA (2000) Renal cell carcinoma: current status and future plans. Cancer J Sci Am 6(Suppl 1):S52–S54
Owens RM, Friedman CD, Becker SP (1989) Renal cell carcinoma with metastasis to the parotid gland: case reports and review of the literature. Head Neck 11:174–178
Batson OV (1967) The vertebral system of veins as a means for cancer dissemination. Prog Clin Cancer 3:1–18
Parnes RE, Goldberg SH, Sassani JW (1993) Renal cell carcinoma metastatic to the orbit: a clinicopathologic report. Ann Ophthalmol 25:100–102
Rathmell WK, Godley PA (2004) Renal cell carcinoma. Curr Opin Oncol 16:247–252
Pantuck AJ (2005) Editorial on Hofmann et al: prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol (in press)
Dawson NA, Guo C, Zak R et al (2004) A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma. Clin Cancer Res 10:7812–7819
Acknowledgment
This study was supported by the Division of Head and Neck Surgery, the Jonsson Comprehensive Cancer, the UCLA School of Medicine, NIH-National Cancer Institute Grant # K23, CA 88921. The authors wish to acknowledge Dr. Thomas Calcaterra for his continued support for this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paiva, M.B., Sercarz, J.A., Pantuck, A.J. et al. Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck. Lasers Med Sci 22, 60–63 (2007). https://doi.org/10.1007/s10103-006-0422-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-006-0422-x